Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FCFQ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,899
Award facts
- Contract value 100% obligated
- $21,899.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On January 16, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $21,899.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, designated as contract number 4570608144, carries an ultimate completion date of February 9, 2026, and was issued without a set-aside designation, indicating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support Department of Defense healthcare operations worldwide. The underlying IDC, valued at $499,999,999 with completion through December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical consumables. As one of multiple regional prime vendor contractors under this program, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and capability across diverse therapeutic categories, positioning it as a critical supplier within the federal pharmaceutical supply chain serving military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DR26FCFQ0?
SPE2DR26FCFQ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FCFQ0 worth?
The government has obligated $21,899 on SPE2DR26FCFQ0.
Is contract SPE2DR26FCFQ0 an order under another contract?
Yes. SPE2DR26FCFQ0 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFQ0 competed?
The extent of competition for SPE2DR26FCFQ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award